MediPharm Labs Balance Sheet Health
Financial Health criteria checks 6/6
MediPharm Labs has a total shareholder equity of CA$53.0M and total debt of CA$2.1M, which brings its debt-to-equity ratio to 4%. Its total assets and total liabilities are CA$63.9M and CA$10.9M respectively.
Key information
4.0%
Debt to equity ratio
CA$2.11m
Debt
| Interest coverage ratio | n/a |
| Cash | CA$18.25m |
| Equity | CA$53.01m |
| Total liabilities | CA$10.93m |
| Total assets | CA$63.94m |
Recent financial health updates
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Jan 10
MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?
Sep 06Is MediPharm Labs (TSE:LABS) Using Too Much Debt?
Mar 07Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Aug 18Recent updates
Market Might Still Lack Some Conviction On MediPharm Labs Corp. (TSE:LABS) Even After 31% Share Price Boost
Mar 23Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Jan 10MediPharm Labs (TSE:LABS) Has Debt But No Earnings; Should You Worry?
Sep 06MediPharm Labs Corp. (TSE:LABS) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 17Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook
Aug 20Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates
May 21Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade
Apr 06Is MediPharm Labs (TSE:LABS) Using Too Much Debt?
Mar 07Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?
Aug 18Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates
May 23Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last Year
Jan 11
Financial Position Analysis
Short Term Liabilities: LABS's short term assets (CA$36.6M) exceed its short term liabilities (CA$10.9M).
Long Term Liabilities: LABS's short term assets (CA$36.6M) exceed its long term liabilities (CA$69.0K).
Debt to Equity History and Analysis
Debt Level: LABS has more cash than its total debt.
Reducing Debt: LABS's debt to equity ratio has reduced from 21.5% to 4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LABS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LABS has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 7.2% each year.